SHL Telemedicine shareholders confirm increase of share capital

SHL Telemedicine Ltd. (SHMLF) submitted a Form 6-K as a foreign private issuer to provide an update to investors.

Rhea-AI Filing Summary

SHL Telemedicine Ltd. (SHMLF) submitted a Form 6-K as a foreign private issuer to provide an update to investors. The company reports that on November 20, 2025 it issued a press release titled “SHL’s shareholders confirm increase of share capital.”

The filing states that this press release is attached as Exhibit 99.1 and incorporated by reference, indicating that SHL’s shareholders have formally confirmed an increase in the company’s share capital. The Form 6-K itself is largely administrative, serving to furnish this press release to the market under U.S. securities law.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SHL Telemedicine Ltd. (SHMLF) report in this Form 6-K?

The Form 6-K reports that SHL Telemedicine Ltd. issued a press release titled “SHL’s shareholders confirm increase of share capital,” which is furnished as Exhibit 99.1 and incorporated by reference.

What key corporate action is mentioned for SHL Telemedicine Ltd. (SHMLF)?

The document states that SHL’s shareholders confirmed an increase of the company’s share capital, as described in a press release dated November 20, 2025.

When did SHL Telemedicine announce the shareholder confirmation of the share capital increase?

On November 20, 2025, SHL Telemedicine Ltd. issued a press release titled “SHL’s shareholders confirm increase of share capital,” which is referenced in this Form 6-K.

Where can investors find the detailed terms of SHL Telemedicine’s share capital increase?

The detailed terms are in the press release furnished as Exhibit 99.1 to this Form 6-K, which is incorporated by reference.

What type of SEC form did SHL Telemedicine Ltd. (SHMLF) file for this update?

SHL Telemedicine Ltd. filed a Form 6-K, which is a report of a foreign private issuer under the Securities Exchange Act of 1934.

Who signed this SHL Telemedicine Ltd. Form 6-K?

The Form 6-K was signed on behalf of SHL Telemedicine Ltd. by Lior Haalman, the company’s Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/20/2025 - 12:00 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-41641

SHL TELEMEDICINE LTD.

(Translation of registrant’s name into English)

 90 Yigal Alon Street

Tel Aviv 67891, Israel

(Address of principal executive offices)

_____________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒          Form 40-F ☐

EXPLANATORY NOTE

On November 20, 2025, SHL Telemedicine Ltd. issued a press release titled “SHL’s shareholders confirm increase of share capital”, a copy of which is furnished herewith as Exhibit 99.1, and which is incorporated by reference herein.

EXHIBIT INDEX

Exhibit Description

99.1 Press release, dated November 20, 2025, titled “SHL’s shareholders confirm increase of share capital”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SHL TELEMEDICINE LTD.
	By:	/s/ Lior Haalman
		Lior Haalman
		Chief Financial Officer

November 20, 2025